Danaher Corp. (NYSE:DHR)’s share price gapped up before the market opened on Friday . The stock had previously closed at $80.51, but opened at $80.52. Danaher Corp. shares last traded at $80.91, with a volume of 795,766 shares traded.

A number of brokerages have recently weighed in on DHR. Credit Suisse Group AG reaffirmed a “hold” rating on shares of Danaher Corp. in a research report on Saturday, July 9th. Zacks Investment Research lowered Danaher Corp. from a “buy” rating to a “hold” rating in a research report on Monday, May 2nd. Bank of America Corp. reaffirmed a “buy” rating on shares of Danaher Corp. in a research report on Sunday, May 29th. Royal Bank Of Canada upped their target price on Danaher Corp. from $96.00 to $99.00 and gave the stock a “sector perform” rating in a research report on Friday, May 27th. Finally, Citigroup Inc. upped their target price on Danaher Corp. from $102.00 to $104.00 and gave the stock a “neutral” rating in a research report on Monday, June 13th. Two equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and ten have assigned a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus target price of $96.86.

The stock’s 50-day moving average price is $81.03 and its 200 day moving average price is $74.43. The firm has a market capitalization of $56.07 billion and a PE ratio of 16.15.

Danaher Corp. (NYSE:DHR) last issued its quarterly earnings data on Monday, July 25th. The company reported $1.25 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.22 by $0.03. The business earned $5.80 billion during the quarter, compared to the consensus estimate of $5.76 billion. During the same quarter in the prior year, the business posted $1.08 earnings per share. Danaher Corp.’s quarterly revenue was up 16.6% compared to the same quarter last year. Analysts expect that Danaher Corp. will post $3.56 earnings per share for the current fiscal year.

In other news, insider Thomas Patrick Joyce, Jr. sold 45,897 shares of Danaher Corp. stock in a transaction that occurred on Monday, August 1st. The stock was sold at an average price of $81.44, for a total value of $3,737,851.68. Following the sale, the insider now directly owns 179,054 shares in the company, valued at approximately $14,582,157.76. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CFO Daniel L. Comas sold 96,446 shares of Danaher Corp. stock in a transaction that occurred on Wednesday, July 27th. The stock was sold at an average price of $80.88, for a total value of $7,800,552.48. Following the completion of the sale, the chief financial officer now owns 215,716 shares in the company, valued at $17,447,110.08. The disclosure for this sale can be found here.

Other large investors have recently added to or reduced their stakes in the company. Eaton Vance Management raised its stake in Danaher Corp. by 14.7% in the fourth quarter. Eaton Vance Management now owns 1,012,781 shares of the company’s stock valued at $94,067,000 after buying an additional 129,443 shares in the last quarter. US Bancorp DE raised its stake in Danaher Corp. by 2.9% in the fourth quarter. US Bancorp DE now owns 209,216 shares of the company’s stock valued at $19,431,000 after buying an additional 5,906 shares in the last quarter. American International Group Inc. raised its stake in Danaher Corp. by 2.1% in the fourth quarter. American International Group Inc. now owns 319,627 shares of the company’s stock valued at $29,687,000 after buying an additional 6,703 shares in the last quarter. Finally, Schwab Charles Investment Management Inc. raised its stake in Danaher Corp. by 3.1% in the fourth quarter. Schwab Charles Investment Management Inc. now owns 1,564,733 shares of the company’s stock valued at $145,333,000 after buying an additional 47,142 shares in the last quarter.

Danaher Corporation designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental, and Industrial Technologies. Its Test & Measurement segment offers products, software and services.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.